Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0469615B2 - - Google Patents
[go: Go Back, main page]

JPH0469615B2 - - Google Patents

Info

Publication number
JPH0469615B2
JPH0469615B2 JP60035594A JP3559485A JPH0469615B2 JP H0469615 B2 JPH0469615 B2 JP H0469615B2 JP 60035594 A JP60035594 A JP 60035594A JP 3559485 A JP3559485 A JP 3559485A JP H0469615 B2 JPH0469615 B2 JP H0469615B2
Authority
JP
Japan
Prior art keywords
extract
skin
lotion
ethanol
purified water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60035594A
Other languages
Japanese (ja)
Other versions
JPS61194030A (en
Inventor
Hisayuki Komazaki
Atsuko Igarashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Priority to JP60035594A priority Critical patent/JPS61194030A/en
Publication of JPS61194030A publication Critical patent/JPS61194030A/en
Publication of JPH0469615B2 publication Critical patent/JPH0469615B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

[産業上の利用分野] 本発明は延命皮抽出物を配合することにより、
創傷治癒、肌荒れ防止、肌荒れ改善の外、皮膚の
たるみ、つやの消失などを防いで老化を防止する
効果に優れた化粧料に関する。 [従来の技術] 延命皮抽出物は抗炎症作用を有することが知ら
れているが、その作用機構は未だ充分に解明され
ていない。 本発明者らは延命皮抽出物が前記のごとく従来
知られている抗炎症作用とは逆の効果である皮膚
細胞増殖促進作用をする事を見いだし、このこと
に着目して延命皮抽出物を配合した化粧料を経皮
的に投与した場合いかなる効果を生じるか鋭意研
究を重ねた結果究を重ねた結果、驚くべきこと
に、延命皮の抽出物を配合した化粧料は、創傷治
癒、肌荒れ防止、肌荒れ改善、老化防止の効果に
優れていることを見いだし、本発明を完成するに
至つた。 [問題点を解決するための手段] すなわち、本発明は延命皮抽出物を配合するこ
とを特徴とする化粧料。 本発明の延命皮抽出物は、例えば以下の方法で
得られる。 延命皮の果実を、溶媒、例えば水、メタノール
やエタノールのような低級アルコール、含水低級
アルコールと共に加熱還流し濾過して得られる抽
出液を濃縮して、得られる。このような方法で得
られた延命皮抽出物をさらに、Highly prous
porlymerに吸着後、メタノールで溶出させて得
る方法等がある。これらの方法で得られた延命皮
抽出物についても優れた効果が見られる。 本発明における延命皮抽出物の配合量は、化粧
料全量中、0.00005−10重量%、好ましくは
0.0001〜5重量%である。0.00005重量%以下で
あると、本発明でいう効果が十分に発揮されず、
好ましくない。 本発明の化粧料は前記の必須成分に加えて必要
に応じて、本発明の効果を損なわない範囲内で、
化粧品、医薬品等に一般に用いられる各種成分、
すなわち水性成分、粉末成分、油分、界面活性
剤、保湿剤、増粘剤、防風剤、酸化防止剤、香
料、色剤、薬剤等を配合することができる。薬剤
の中でも特にL−アスコルビン酸又はそのエステ
ルを配合した時、顕著な効果が発揮される。また
本発明の化粧料の剤型は任意であり、例えば化粧
水等の可溶化系、乳液、クリーム等の乳化系ある
いは軟膏、分散液、などの剤型をとることができ
る。 [発明の効果及び実施例] 延命皮抽出物の皮膚の創傷治癒、肌荒防止、肌
荒改善効果及び皮膚のたるみ、つやの消失などの
老化防止効果を示すために次の皮膚細胞増殖促進
作用の試験を行つた。 (皮膚細胞増殖促進作用) ヒト皮膚組織を細片し、細胞培養用シヤーレの
底面に付着させてEagle'sMEM培養液(10%牛
胎児血清含有)中で1週間培養するとシヤーレの
底面がほぼ全面に線維芽細胞で満たされる。この
線維芽細胞を0.25%トリプシン溶液で処理するこ
とによつて単一細胞とし、次に10000コ細胞/ml
の細胞浮遊液をつくり、この溶液をシヤーレ当た
り0.1ml加え、Eagle'sMEM培養液及び延命皮抽
出物(最終濃度20μg/ml)を更に加えてCO2
インキユベター中で2週間培養し、その後細胞固
定して染色した後、細胞のコロニーを計測した。
なお延命皮抽出物を添加しない場合をコントロー
ルとした。結果を第1図に示す。コロニー形成率
は次式によつて算出した。 コロニー形成率=T/C×100(%) T=延命皮抽出物を処理した細胞のコロニー数/シヤー
レ当たりの植え込みの細胞数 T=
延命皮抽出物を処理しない細胞のコロニー数/シヤーレ
当たりの植え込み細胞数 第1図に示す如区、延命皮抽出物はコントロー
ルに比べていずれも著明な効果を示した。 更に皮膚に対する創傷治癒効果を示すために次
の試験を行つた。 (創傷治癒効果) 生後8週令のウイスター系ラツト(雄)を5匹
1群とし、毛刈の後、試験に供した。ラツトはネ
ンブタールにより麻酔後正中線にそつて、約2cm
背部皮膚を切開し、ただちに切開部をミツヘル縫
合後、延命皮抽出物0.05gを生食溶液0.1mlに溶
解して1日1回2週間塗布した。縫合針は3〜4
日後に外した。2週間後、ラツトを死亡させ、切
開部を中心に幅2cmの短冊状の皮膚切片を作成し
た。張力測定にはテンシロンUTM−4(東洋測
器株式会社製)を用い皮膚切片の切断弾力を測定
した。尚、コントロールは延命皮抽出物を含まな
い生理食塩水を塗布した皮膚切片を用いた。 結果を第1表に示す。
[Industrial Application Field] The present invention provides the following benefits:
The present invention relates to cosmetics that are effective in healing wounds, preventing skin roughness, improving skin roughness, and preventing aging by preventing skin sagging and loss of luster. [Prior Art] Although it is known that the extract of Enmeihiki has an anti-inflammatory effect, its mechanism of action has not yet been fully elucidated. The present inventors have discovered that Enmeihiki extract has a skin cell growth promoting effect, which is the opposite of the previously known anti-inflammatory effect, and focusing on this, we have developed Enmeihiki extract. As a result of extensive research into the effects of transdermal administration of the formulated cosmetics, we have surprisingly found that cosmetics containing Enmeihiki extracts are effective against wound healing and rough skin. They discovered that it has excellent effects in preventing rough skin, improving skin roughness, and preventing aging, leading to the completion of the present invention. [Means for Solving the Problems] That is, the present invention provides a cosmetic characterized by blending an extract of Enmei skin. The Enmeihiki extract of the present invention can be obtained, for example, by the following method. It is obtained by heating and refluxing and filtering the Enmeihi fruit with a solvent such as water, a lower alcohol such as methanol or ethanol, or a water-containing lower alcohol, and concentrating the resulting extract. The extract obtained by this method is further added to Highly prous.
There are methods such as adsorption to polymer and elution with methanol. Excellent effects are also seen with the Enmeihihi extract obtained by these methods. In the present invention, the blending amount of Enmeiha extract is 0.00005-10% by weight, preferably 0.00005-10% by weight based on the total amount of cosmetic
It is 0.0001 to 5% by weight. If it is less than 0.00005% by weight, the effect of the present invention will not be sufficiently exhibited,
Undesirable. In addition to the above-mentioned essential ingredients, the cosmetic of the present invention may contain, if necessary, within a range that does not impair the effects of the present invention.
Various ingredients commonly used in cosmetics, pharmaceuticals, etc.
That is, an aqueous component, a powder component, an oil component, a surfactant, a humectant, a thickener, a windproof agent, an antioxidant, a fragrance, a coloring agent, a drug, etc. can be blended. Among the drugs, particularly when L-ascorbic acid or its ester is blended, remarkable effects are exhibited. Further, the dosage form of the cosmetic of the present invention is arbitrary, and can be, for example, a solubilized system such as a lotion, an emulsified system such as a milky lotion or a cream, or a dosage form such as an ointment or a dispersion. [Effects and Examples of the Invention] In order to demonstrate the skin wound healing, skin roughness prevention, skin roughness improvement effects, and anti-aging effects such as skin sagging and loss of luster of the protracted skin extract, the following skin cell growth promoting effects were demonstrated. I conducted a test. (Skin cell growth promotion effect) When human skin tissue is cut into small pieces, attached to the bottom of a cell culture shear dish, and cultured for one week in Eagle's MEM culture solution (containing 10% fetal bovine serum), almost the entire bottom of the shear dish is covered. filled with fibroblasts. The fibroblasts were made into single cells by treatment with 0.25% trypsin solution and then reduced to 10000 cells/ml.
Prepare a cell suspension, add 0.1 ml of this solution per shear dish, add Eagle's MEM culture solution and Enmei skin extract (final concentration 20 μg/ml), and add CO 2 -
After culturing in an incubator for two weeks, the cells were fixed and stained, and then cell colonies were counted.
The case in which Enmeihiki extract was not added was used as a control. The results are shown in Figure 1. Colony formation rate was calculated using the following formula. Colony formation rate = T/C x 100 (%) T = Number of colonies of cells treated with Enmeihihi extract/Number of cells implanted per shear T =
Number of colonies of cells not treated with Enmeihi extract/Number of implanted cells per sheared area As shown in Figure 1, the Enmeihi extract showed a remarkable effect compared to the control. Furthermore, the following test was conducted to demonstrate the wound healing effect on the skin. (Wound Healing Effect) Groups of five 8-week-old Wistar rats (male) were subjected to a test after their hair was shaved. After the rat was anesthetized with Nembutal, it was placed approximately 2 cm along the midline.
An incision was made on the back skin, and the incision was immediately sutured with Mitsuhel sutures, and 0.05 g of Enmeihi skin extract dissolved in 0.1 ml of saline solution was applied once a day for 2 weeks. 3 to 4 suture needles
I took it off after a day. Two weeks later, the rats were sacrificed and a 2 cm wide strip of skin was cut around the incision site. Tension was measured using Tensilon UTM-4 (manufactured by Toyo Sokki Co., Ltd.) to measure the cutting elasticity of the skin section. Note that, as a control, a skin section coated with physiological saline not containing Enmeihikin extract was used. The results are shown in Table 1.

【表】 第1表の結果から、延命皮抽出物塗布部位はい
ずれも無塗布部(コントロール)に比べ張力が増
加し、顕著な治癒促進効果が認められた。 次に実施例によつて本発明をさらに詳細に説明
する。尚、本発明はこれにより限定されるもので
はない。配合量は重量%である。 実施例 1 化粧水 (1) 延命皮抽出物 0.05 (2) グリセリン 4.0 (3) 1.3−ブチレングリコール 4.0 (4) エタノール 7.0 (5) ポリオキシエチレンオレイルアルコール0.5 (6) メチルパラベン 0.5 (7) クエン酸 0.01 (8) クエン酸ソーダ 0.1 (9) 香料 0.05 (10) 精製水 84.24 (製法) 精製水にクエン酸、クエン酸ソーダ、グリセリ
ン、1.3−ブチレングリコール、延命比、を溶解
する。別にエタノールにポリオキシエチレンオレ
イルアルコール、香料、メチルパラベンを溶解
し、これを前述の精製水溶液に加えて可溶化し、
ろ過して化粧水を得た。 実施例 2 クリーム (1) セトステアリルアルコール 3.5 (2) スクワラン 40.0 (3) ミツロウ 3.0 (4) 還元ラノリン 5.0 (5) エチルパラベン 0.3 (6) ポリオキシエチレン(20)ソルビタンモノパルミ
チン酸エステル 2.0 (7) ステアリン酸モノグリセリド 2.0 (8) 延命皮抽出物(第1図の3の物) 1.0 (9) 香料 0.03 (10) 1.3−ブチレングリコール 5.0 (11) グリセリン 5.0 (12) 精製水 33.17 (製法) (1)(2)(3)(4)(5)(6)(7)と(9)を加熱溶解し75℃に保つ

ものを、75℃に加温した(8)(10)(11)と(12)に撹拌しな

ら加える。ホモミキサー処理し乳化粒子を細かく
した後、撹拌しながら急冷し、クリームを得た。 実施例 3 乳液 (1) 延命皮抽出物(第1図の4の物) 0.0001 (2) ステアリン酸 1.5 (3) セチルアルコール 0.5 (4) ミツロウ 2.0 (5) ポリオキシエチレン(10)モノオレイン酸エステ
ル 1.0 (6) グリセリンモノステアリン酸エステル 1.0 (7) クインスシード抽出物(5%水溶液) 20.0 (8) プロピレングリコール 5.0 (9) エタノール 3.0 (10) エチルパラベン 0.3 (11) 香料 0.03 (12) 精製水 残余 (製法) エタノールに香料を加えて溶解する(アルコー
ル相)。 精製水にプロピレングリコールを加え加熱溶解
して70℃に保つ(水相)。クインスシード抽出物
を除く他の成分を混合し、加熱溶解して70℃に保
つ(油相)。水相に油相を加え予備乳化を行い、
ホモミキサーで均一に乳化する。これを撹拌しな
がらアルコール相とクインスシード抽出物を加え
る。その後撹拌しながら30℃に冷却して乳液を得
た。 実施例 4 パツク (1) 延命皮抽出物(第1図の3の物) 0.1 (2) ポリビニルアルコール 15.0 (3) ポリエチレングリコール 3.0 (4) プロピレングリコール 7.0 (5) エタノール 10.0 (6) メチルパラベン 0.05 (7) 香料 0.05 (8) 精製水 64.80 (製法) 精製水にポリエチレングリコール、プロピレン
グリコール、メチルパラベン、延命皮抽出物を加
え撹拌溶解する。つぎにポリビニルアルコールを
加え加熱撹拌し、香料を溶解したエタノールを加
え撹拌溶解してパツクを得た。 実施例 5 頭皮用化粧料(スカルプトリートメント) (1) 延命皮抽出物(第1図の2の物) 0.5 (2) 1,3−ブチレングリコール 6.5 (3) ポリエチレングリコール1500 5.0 (4) エタノール 5.5 (5) 苛性カリ 0.05 (6) 精製水 46.95 (7) 2−ヘキシルデシルパルミテート 10.0 (8) スクワラン 5.0 (9) ブチルパラベン 0.2 (10) ビタミンC 0.15 (11) 香料 0.05 (12) 精製水 19.9 (13) カルボキシビニルポリマー 0.2 (製法) (7)(8)(9)(10)と(11)を75℃で溶解したものを、75℃

保つた(1)(2)(3)(4)と(6)に撹拌しながら添加し、さら
に、室温で撹拌溶解した(5)(12)と(13)を添加し、撹拌
しながら冷却してスカルプトリートメントを得
た。 実施例 6 軟膏 (1) 延命皮抽出物 5.0 (2) ステアリルアルコール 18.0 (3) モクロウ 20.0 (4) ポリオキシエチレン(10)モノオレイン酸エステ
ル 0.25 (5) グリセリンモノステアリン酸エステル 0.25 (6) ワセリン 40.0 (7) 精製水 16.5 (製法) 精製水を70℃に保ち(水相)。他の成分を70℃
にて混合溶解する(油相)。水相に油相を加え、
ホモミキサーで均一に乳化後冷却して軟膏を得
た。延命皮抽出物(*)は延皮命の果実をメタノ
ールで抽出し、抽出物をポリスチレン系樹脂に吸
着後、メタノールで溶出したフラクシヨンであ
る。 (肌荒れ改善効果) 実施例1で得た化粧水とブランク化粧水[延命
皮抽出物を配合しないもの(精製水で置換)]を
用いて人体パネルで肌荒れ改善効果試験を行つ
た。 すなわち、女性健常人(顔面)の皮膚表面形態
をミリスン樹脂によりレプリカ法を用いて肌のレ
プリカを取り顕微鏡(17倍)にて観察する。 皮紋の状態及び角層の剥離状態から表−2に示
す基準にもとづいて肌荒れ評価1、2と判断され
た者(肌荒れパネル)25名を用い、顔面左右半々
に、実施例1で得た化粧水とブランク化粧水を1
日1回2週間塗布した。 2週間後、再び上述のレプリカ法にて肌の状態
を観察し、表−2の判定基準に従つて評価した。
[Table] From the results shown in Table 1, tension increased in all areas where the Enmei peel extract was applied compared to the unapplied area (control), and a significant healing promoting effect was observed. Next, the present invention will be explained in more detail with reference to Examples. Note that the present invention is not limited to this. The blending amount is in weight%. Example 1 Lotion (1) Enmei skin extract 0.05 (2) Glycerin 4.0 (3) 1.3-butylene glycol 4.0 (4) Ethanol 7.0 (5) Polyoxyethylene oleyl alcohol 0.5 (6) Methylparaben 0.5 (7) Citric acid 0.01 (8) Sodium citrate 0.1 (9) Flavor 0.05 (10) Purified water 84.24 (Production method) Dissolve citric acid, sodium citrate, glycerin, 1.3-butylene glycol, and life extension ratio in purified water. Separately, polyoxyethylene oleyl alcohol, fragrance, and methylparaben were dissolved in ethanol, and this was added to the purified aqueous solution described above to solubilize.
A lotion was obtained by filtration. Example 2 Cream (1) Cetostearyl alcohol 3.5 (2) Squalane 40.0 (3) Beeswax 3.0 (4) Reduced lanolin 5.0 (5) Ethylparaben 0.3 (6) Polyoxyethylene (20) Sorbitan monopalmitate ester 2.0 (7) ) Stearic acid monoglyceride 2.0 (8) Enmeihiki extract (item 3 in Figure 1) 1.0 (9) Fragrance 0.03 (10) 1.3-butylene glycol 5.0 (11) Glycerin 5.0 (12) Purified water 33.17 (Production method) ( 1)(2)(3)(4)(5)(6)(7) and (9) were heated and melted and kept at 75℃. ) and (12) while stirring. After processing with a homomixer to make emulsified particles fine, the mixture was rapidly cooled while stirring to obtain cream. Example 3 Emulsion (1) Enmeihihi extract (item 4 in Figure 1) 0.0001 (2) Stearic acid 1.5 (3) Cetyl alcohol 0.5 (4) Beeswax 2.0 (5) Polyoxyethylene (10) Monooleic acid Ester 1.0 (6) Glycerin monostearate 1.0 (7) Quince seed extract (5% aqueous solution) 20.0 (8) Propylene glycol 5.0 (9) Ethanol 3.0 (10) Ethylparaben 0.3 (11) Fragrance 0.03 (12) Purification Water Residual (manufacturing method) Add fragrance to ethanol and dissolve (alcohol phase). Add propylene glycol to purified water, heat to dissolve, and keep at 70℃ (water phase). Mix other ingredients except quince seed extract, heat and dissolve and keep at 70℃ (oil phase). Pre-emulsification is performed by adding the oil phase to the water phase.
Uniformly emulsify with a homomixer. While stirring, add the alcohol phase and quince seed extract. Thereafter, the mixture was cooled to 30° C. while stirring to obtain a milky lotion. Example 4 Pack (1) Enmeihihi extract (3 in Figure 1) 0.1 (2) Polyvinyl alcohol 15.0 (3) Polyethylene glycol 3.0 (4) Propylene glycol 7.0 (5) Ethanol 10.0 (6) Methylparaben 0.05 ( 7) Fragrance 0.05 (8) Purified water 64.80 (Production method) Add polyethylene glycol, propylene glycol, methylparaben, and Enmeihi extract to purified water and stir to dissolve. Next, polyvinyl alcohol was added and stirred while heating, and ethanol in which the fragrance had been dissolved was added and dissolved with stirring to obtain a pack. Example 5 Cosmetics for the scalp (scalp treatment) (1) Extract of Elongated Skin (item 2 in Figure 1) 0.5 (2) 1,3-butylene glycol 6.5 (3) Polyethylene glycol 1500 5.0 (4) Ethanol 5.5 (5) Caustic potassium 0.05 (6) Purified water 46.95 (7) 2-hexyldecyl palmitate 10.0 (8) Squalane 5.0 (9) Butylparaben 0.2 (10) Vitamin C 0.15 (11) Fragrance 0.05 (12) Purified water 19.9 ( 13) Carboxyvinyl polymer 0.2 (manufacturing method) (7)(8)(9)(10) and (11) were dissolved at 75℃.
Add (1), (2), (3), (4) and (6), which were kept at room temperature, with stirring, and then add (5), (12) and (13), which had been stirred and dissolved at room temperature. Cooled and got scalp treatment. Example 6 Ointment (1) Extended skin extract 5.0 (2) Stearyl alcohol 18.0 (3) Mokuro 20.0 (4) Polyoxyethylene (10) monooleate 0.25 (5) Glycerin monostearate 0.25 (6) Vaseline 40.0 (7) Purified water 16.5 (Production method) Keep purified water at 70℃ (aqueous phase). Other ingredients at 70℃
Mix and dissolve (oil phase). Add the oil phase to the water phase,
The mixture was uniformly emulsified using a homomixer and cooled to obtain an ointment. Enmeihiki extract (*) is a fraction obtained by extracting the Enmeipi fruit with methanol, adsorbing the extract on polystyrene resin, and eluting it with methanol. (Skin improvement effect) A skin improvement effect test was conducted on a human body panel using the lotion obtained in Example 1 and a blank lotion [not containing the Enmei skin extract (replaced with purified water)]. That is, a replica of the skin surface of a healthy female person (face) is taken using the replica method using Millisne resin and observed under a microscope (17x magnification). The samples were obtained in Example 1 on the left and right half of the face of 25 people (skin panel) who were judged to have a skin roughness rating of 1 or 2 based on the criteria shown in Table 2 based on the condition of skin marks and peeling of the stratum corneum. 1 lotion and 1 blank lotion
It was applied once a day for 2 weeks. Two weeks later, the skin condition was observed again using the replica method described above and evaluated according to the criteria in Table 2.

【表】【table】

【表】 結果を表−3に示す。【table】 The results are shown in Table-3.

【表】 この結果より、延命皮抽出物配合の化粧水を使
用した顔面部位はブランク化粧水を使用した顔面
部位と比較し、顕著な肌荒れ改善効果が認められ
た。
[Table] From the results, it was found that the facial area using the lotion containing Enmei skin extract had a remarkable effect on improving rough skin compared to the facial area using the blank lotion.

【図面の簡単な説明】[Brief explanation of the drawing]

第1図は本発明に係る化粧料の皮膚細胞増殖効
果を示すグラフである。 1はコントロールすなわち延命皮抽出物を添加
していないものである。2は延命皮を水にて抽出
し、得た抽出物を添加したものである。3は2の
濃縮物を50%エタノールに溶解し、ポリスチレン
系樹脂に吸着したものを含水メタノールで溶出し
た後濃縮下物である。4は延命皮の50%エタノー
ル抽出物である。
FIG. 1 is a graph showing the skin cell proliferation effect of the cosmetic according to the present invention. 1 is a control, ie, one in which no Enmeihihi extract was added. 2 is a product obtained by extracting Enmeihihi with water and adding the obtained extract. 3 is the product obtained by dissolving the concentrate of 2 in 50% ethanol, eluting the adsorbed material on the polystyrene resin with water-containing methanol, and then concentrating it. 4 is a 50% ethanol extract of Enmeiha.

Claims (1)

【特許請求の範囲】[Claims] 1 延命皮抽出物(Sapindus muku−rossi
Gaertn.)を配合することを特徴とする化粧料。
1 Sapindus muku-rossi extract (Sapindus muku-rossi)
A cosmetic product characterized by containing the following: Gaertn.).
JP60035594A 1985-02-25 1985-02-25 Cosmetic Granted JPS61194030A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60035594A JPS61194030A (en) 1985-02-25 1985-02-25 Cosmetic

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60035594A JPS61194030A (en) 1985-02-25 1985-02-25 Cosmetic

Publications (2)

Publication Number Publication Date
JPS61194030A JPS61194030A (en) 1986-08-28
JPH0469615B2 true JPH0469615B2 (en) 1992-11-06

Family

ID=12446122

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60035594A Granted JPS61194030A (en) 1985-02-25 1985-02-25 Cosmetic

Country Status (1)

Country Link
JP (1) JPS61194030A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6267027A (en) * 1985-09-18 1987-03-26 Shiseido Co Ltd Dermal drug for external use
JPH05301821A (en) * 1992-04-23 1993-11-16 Kao Corp Medicated cosmetic
EP1938827A4 (en) * 2005-09-16 2010-07-21 Shiseido Co Ltd NOVEL INHIBITOR OF VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION
CN105802732B (en) * 2016-04-27 2019-08-06 和和实业股份有限公司 Separation method of soapberry kernel oil separation matter

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2487356A1 (en) * 1980-07-25 1982-01-29 Oreal STABLE EMULSIONS OBTAINED FROM A NATURAL EMULSIFYING AGENT STABILIZED BY ALOE SUCK
JPS597106A (en) * 1982-07-06 1984-01-14 Shiseido Co Ltd Emulsifiable composition

Also Published As

Publication number Publication date
JPS61194030A (en) 1986-08-28

Similar Documents

Publication Publication Date Title
JPH0517206B2 (en)
EP1226822B1 (en) Promoter for production of nitric oxide or nitric oxide synthase, and cosmetic or pharmaceutical composition comprising the same
JPS6261924A (en) Dermatic agent for external use
JP3251635B2 (en) External preparation for skin
JPS6379809A (en) Skin drug for external use
JP3667027B2 (en) Topical skin preparation
JPH0469615B2 (en)
JPS625909A (en) Preventing agent for skin elastosis
JPS61205204A (en) External preparation for skin
JP3443130B2 (en) External preparation for skin
JP3522609B2 (en) Hyaluronic acid production promoter and skin external preparation containing the same
JPH0436137B2 (en)
US4296099A (en) Process for extracting embryonic calf skin and pharmaceutical compositions containing the same
JPH0296581A (en) Biotin ester and skin ointment and hair tonic using the ester
JPH11171784A (en) External preparation for skin
JP3135295B2 (en) External preparation for skin
JPS61254510A (en) External agent for skin
JP3135294B2 (en) External preparation for skin
JP2531679B2 (en) Topical
JPH06219958A (en) Melanogenesis suppressing agent and external agent for skin
JPH11116604A (en) External preparation for skin
JP2000143527A (en) Hyaluronic acid production promoter and skin preparation for external use containing the same
JP2829157B2 (en) External preparation for skin
JP2906173B2 (en) External preparation for skin
KR20100103041A (en) Cosmetic composition including an extract of chelidonium majus l. having skin whitening effect)